ASND News
Ascendis Pharma A/S
$227.00
+$3.79(+1.70%)
38
Overall
20
Value
27
Tech
68
Quality
Market Cap
$14.96B
Volume
995.68K
52W Range
$186.05 - $282.15
Target Price
$314.75
ASND news: the latest Ascendis Pharma A/S headlines, press releases and market updates, newest first.
Latest ASND News
- Ascendis Pharma (ASND) Receives a New Rating from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Ascendis Pharma Grants New Employee Warrants and Updates Articles of AssociationTipRanks Auto-Generated Newsdesk · Oct 14, 2026
- RBC Capital Sticks to Its Buy Rating for Ascendis Pharma (ASND)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Cytokinetics (CYTK)TipRanks Newsroom · Oct 3, 2026
- Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Ascendis Pharma (ASND)TipRanks Newsroom · Sep 21, 2026
- Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Ascendis Pharma (ASND) and BridgeBio Oncology Therapeutics (BBOT)TipRanks Newsroom · Sep 15, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASND | $227.00 | +1.7% | 995.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |